In this section you will find Selcia news and up-coming events Selcia is attending.
News & Events
Sp2 Magazine has published an article in its recent issue showcasing Selcia's successful Drug Discovery and Radiolabelling divisions.
Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration
Selcia has successfully completed 14C radiolabelled API projects on behalf of a diverse range of clients for phase 1 human trials, following MHRA GMP Certification in September 2010.
Selcia are proud to announce the publication of the latest poster on our proprietary CEfrag™ fragment screening technology.
It is with great sadness that we report the loss of two friends, Jim Little and Bruce Lowery.